
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Triglyceride Metabolism in the Liver
Michele Alves‐Bezerra, David E. Cohen
Comprehensive physiology (2017), pp. 1-22
Open Access | Times Cited: 970
Michele Alves‐Bezerra, David E. Cohen
Comprehensive physiology (2017), pp. 1-22
Open Access | Times Cited: 970
Showing 26-50 of 970 citing articles:
Lipid Metabolism, Disorders and Therapeutic Drugs - Review
Natesan Vijayakumar, Sung‐Jin Kim
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 6, pp. 596-604
Open Access | Times Cited: 104
Natesan Vijayakumar, Sung‐Jin Kim
Biomolecules & Therapeutics (2021) Vol. 29, Iss. 6, pp. 596-604
Open Access | Times Cited: 104
Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites
Yufang Ding, Karin Yanagi, Clint Cheng, et al.
Pharmacological Research (2019) Vol. 141, pp. 521-529
Open Access | Times Cited: 101
Yufang Ding, Karin Yanagi, Clint Cheng, et al.
Pharmacological Research (2019) Vol. 141, pp. 521-529
Open Access | Times Cited: 101
<p>Glucocorticoid-Induced Fatty Liver Disease</p>
Leili Rahimi, Aman Rajpal, Faramarz Ismail‐Beigi
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 1133-1145
Open Access | Times Cited: 101
Leili Rahimi, Aman Rajpal, Faramarz Ismail‐Beigi
Diabetes Metabolic Syndrome and Obesity (2020) Vol. Volume 13, pp. 1133-1145
Open Access | Times Cited: 101
Mechanisms and Treatment of Dyslipidemia in Diabetes
Ehete Bahiru, Ruth Hsiao, Daniel Phillipson, et al.
Current Cardiology Reports (2021) Vol. 23, Iss. 4
Closed Access | Times Cited: 100
Ehete Bahiru, Ruth Hsiao, Daniel Phillipson, et al.
Current Cardiology Reports (2021) Vol. 23, Iss. 4
Closed Access | Times Cited: 100
Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCC
Hyun-Mi Kim, Da Som Lee, Tae Hyeon An, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4495-4495
Open Access | Times Cited: 100
Hyun-Mi Kim, Da Som Lee, Tae Hyeon An, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4495-4495
Open Access | Times Cited: 100
Oleanolic Acid Targets the Gut–Liver Axis to Alleviate Metabolic Disorders and Hepatic Steatosis
Chenyu Xue, Ying Li, Hao Lv, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 28, pp. 7884-7897
Closed Access | Times Cited: 93
Chenyu Xue, Ying Li, Hao Lv, et al.
Journal of Agricultural and Food Chemistry (2021) Vol. 69, Iss. 28, pp. 7884-7897
Closed Access | Times Cited: 93
Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder
Junjian Hu, Hongwu Wang, Xitang Li, et al.
Theranostics (2020) Vol. 10, Iss. 21, pp. 9702-9720
Open Access | Times Cited: 78
Junjian Hu, Hongwu Wang, Xitang Li, et al.
Theranostics (2020) Vol. 10, Iss. 21, pp. 9702-9720
Open Access | Times Cited: 78
Hepatic transcriptional responses to fasting and feeding
Lara Bideyan, Rohith T. Nagari, Peter Tontonoz
Genes & Development (2021) Vol. 35, Iss. 9-10, pp. 635-657
Open Access | Times Cited: 75
Lara Bideyan, Rohith T. Nagari, Peter Tontonoz
Genes & Development (2021) Vol. 35, Iss. 9-10, pp. 635-657
Open Access | Times Cited: 75
Pharmacological aspects of ANGPTL3 and ANGPTL4 inhibitors: New therapeutic approaches for the treatment of atherogenic dyslipidemia
Massimiliano Ruscica, Francesca Zimetti, Maria Pia Adorni, et al.
Pharmacological Research (2020) Vol. 153, pp. 104653-104653
Open Access | Times Cited: 72
Massimiliano Ruscica, Francesca Zimetti, Maria Pia Adorni, et al.
Pharmacological Research (2020) Vol. 153, pp. 104653-104653
Open Access | Times Cited: 72
Overexpression of NAG-1/GDF15 prevents hepatic steatosis through inhibiting oxidative stress-mediated dsDNA release and AIM2 inflammasome activation
Ying Wang, Chaojie Chen, Jiajun Chen, et al.
Redox Biology (2022) Vol. 52, pp. 102322-102322
Open Access | Times Cited: 68
Ying Wang, Chaojie Chen, Jiajun Chen, et al.
Redox Biology (2022) Vol. 52, pp. 102322-102322
Open Access | Times Cited: 68
Dietary lipids from body to brain
Custers, E.M. Emma, Kiliaan, et al.
Progress in Lipid Research (2021) Vol. 85, pp. 101144-101144
Open Access | Times Cited: 67
Custers, E.M. Emma, Kiliaan, et al.
Progress in Lipid Research (2021) Vol. 85, pp. 101144-101144
Open Access | Times Cited: 67
Nonalcoholic fatty liver disease stratification by liver lipidomics
Olga Vvedenskaya, Tim Rose, Oskar Knittelfelder, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100104-100104
Open Access | Times Cited: 57
Olga Vvedenskaya, Tim Rose, Oskar Knittelfelder, et al.
Journal of Lipid Research (2021) Vol. 62, pp. 100104-100104
Open Access | Times Cited: 57
Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
Vera Francisco, María‐Jesús Sanz, José T. Real, et al.
Biology (2022) Vol. 11, Iss. 8, pp. 1237-1237
Open Access | Times Cited: 54
Vera Francisco, María‐Jesús Sanz, José T. Real, et al.
Biology (2022) Vol. 11, Iss. 8, pp. 1237-1237
Open Access | Times Cited: 54
Lack of VMP1 impairs hepatic lipoprotein secretion and promotes non-alcoholic steatohepatitis
Xiaoxiao Jiang, Sam Fulte, Fengyan Deng, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 619-631
Open Access | Times Cited: 49
Xiaoxiao Jiang, Sam Fulte, Fengyan Deng, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 3, pp. 619-631
Open Access | Times Cited: 49
The SGLT2 inhibitor dapagliflozin promotes systemic FFA mobilization, enhances hepatic β-oxidation, and induces ketosis
Kristina Wallenius, Tobias Kroon, Therese Hagstedt, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 3, pp. 100176-100176
Open Access | Times Cited: 48
Kristina Wallenius, Tobias Kroon, Therese Hagstedt, et al.
Journal of Lipid Research (2022) Vol. 63, Iss. 3, pp. 100176-100176
Open Access | Times Cited: 48
Race and Ethnicity in Non-Alcoholic Fatty Liver Disease (NAFLD): A Narrative Review
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4556-4556
Open Access | Times Cited: 45
Kiarash Riazi, Mark G. Swain, Stephen E. Congly, et al.
Nutrients (2022) Vol. 14, Iss. 21, pp. 4556-4556
Open Access | Times Cited: 45
Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verification
Guoyan Jiang, Chunhong Sun, Xiaodong Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5216-5235
Open Access | Times Cited: 44
Guoyan Jiang, Chunhong Sun, Xiaodong Wang, et al.
Bioengineered (2022) Vol. 13, Iss. 3, pp. 5216-5235
Open Access | Times Cited: 44
Biogenic Phytochemicals Modulating Obesity: From Molecular Mechanism to Preventive and Therapeutic Approaches
Vikram Kumar, Desh Deepak Singh, Sudarshan Singh Lakhawat, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 44
Vikram Kumar, Desh Deepak Singh, Sudarshan Singh Lakhawat, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 44
The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence
Karla Paulina Luna-Castillo, Xochitl Citlalli Olivares-Ochoa, Rocío Guadalupe Hernández-Ruiz, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 1104-1104
Open Access | Times Cited: 42
Karla Paulina Luna-Castillo, Xochitl Citlalli Olivares-Ochoa, Rocío Guadalupe Hernández-Ruiz, et al.
Nutrients (2022) Vol. 14, Iss. 5, pp. 1104-1104
Open Access | Times Cited: 42
Fructose impairs fat oxidation: Implications for the mechanism of western diet-induced NAFLD
Mustafa Kutlu Inci, Sehyung Park, Robert N. Helsley, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 114, pp. 109224-109224
Open Access | Times Cited: 41
Mustafa Kutlu Inci, Sehyung Park, Robert N. Helsley, et al.
The Journal of Nutritional Biochemistry (2022) Vol. 114, pp. 109224-109224
Open Access | Times Cited: 41
Novel Insights into the Emerging Role of Neat1 and Its Effects Downstream in the Regulation of Inflammation
Yongli Pan, Ting Wang, Zhiqiang Zhao, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 557-571
Open Access | Times Cited: 39
Yongli Pan, Ting Wang, Zhiqiang Zhao, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 557-571
Open Access | Times Cited: 39
Dietary berberine alleviates high carbohydrate diet-induced intestinal damages and improves lipid metabolism in largemouth bass (Micropterus salmoides)
Yulong Gong, Qisheng Lu, Yulong Liu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39
Yulong Gong, Qisheng Lu, Yulong Liu, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 39
Insulin resistance and adipose tissue interactions as the cornerstone of metabolic (dysfunction)-associated fatty liver disease pathogenesis
Shreya C. Pal, Nahúm Méndez‐Sánchez
World Journal of Gastroenterology (2023) Vol. 29, Iss. 25, pp. 3999-4008
Open Access | Times Cited: 37
Shreya C. Pal, Nahúm Méndez‐Sánchez
World Journal of Gastroenterology (2023) Vol. 29, Iss. 25, pp. 3999-4008
Open Access | Times Cited: 37
Large neutral amino acid levels tune perinatal neuronal excitability and survival
Lisa S. Knaus, Bernadette Basilico, Daniel Malzl, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1950-1967.e25
Open Access | Times Cited: 33
Lisa S. Knaus, Bernadette Basilico, Daniel Malzl, et al.
Cell (2023) Vol. 186, Iss. 9, pp. 1950-1967.e25
Open Access | Times Cited: 33
Lipid Metabolism in Metabolic-Associated Steatotic Liver Disease (MASLD)
Majid Mufaqam Syed‐Abdul
Metabolites (2023) Vol. 14, Iss. 1, pp. 12-12
Open Access | Times Cited: 33
Majid Mufaqam Syed‐Abdul
Metabolites (2023) Vol. 14, Iss. 1, pp. 12-12
Open Access | Times Cited: 33